RHDV1 (classic VHD)

RHDV1, commonly referred to as classic Viral Hemorrhagic Disease (VHD) or classic Rabbit Hemorrhagic Disease (RHD), represents the original strain of rabbit hemorrhagic disease virus that emerged in the 1980s and caused devastating epidemics in rabbit populations worldwide. This highly lethal calicivirus was first identified in 1984 in domestic European rabbits imported from Germany to China, and within years it had spread to nearly every continent where rabbits are raised. RHDV1 causes acute, fatal liver disease characterized by massive hepatic necrosis and disseminated intravascular coagulation, resulting in hemorrhaging from multiple organs and rapid death. The virus specifically targets domestic European rabbits (Oryctolagus cuniculus) and has been responsible for massive losses in both commercial rabbitries and pet populations.

The classic RHDV1 strain causes infection through the same mechanisms as other lagoviruses, targeting liver cells and causing overwhelming organ failure within hours of symptom onset. A distinctive characteristic of RHDV1 compared to the newer RHDV2 variant is its age-related susceptibility pattern. Classic RHDV1 primarily causes fatal disease in adult rabbits over eight to ten weeks of age, while young rabbits under this age typically remain protected by maternal antibodies and may not develop clinical disease even when exposed. This age resistance provided some natural protection for young kits in affected populations, though it did not prevent massive die-offs among adult breeding stock. The virus spreads through direct contact, contaminated materials, and environmental persistence, with mortality rates reaching 70 to 90 percent in susceptible adult populations.

The historical impact of RHDV1 on global rabbit populations was catastrophic when the virus first emerged and spread. Commercial rabbitries experienced devastating losses, with some operations losing their entire adult breeding populations within days of disease introduction. Wild European rabbit populations in areas where the virus was endemic suffered significant population crashes. The economic impact on the rabbit meat and fur industries was substantial, particularly in Europe, Asia, and Australia. Interestingly, in Australia, RHDV1 was deliberately released as a biological control agent to reduce feral rabbit populations that were causing extensive environmental damage. This controlled release demonstrated both the lethality of the virus and its effectiveness at reducing rabbit numbers, though it also raised concerns about potential spread to domestic rabbits.

While RHDV1 remains present in some regions of the world, it has been largely displaced by the newer RHDV2 variant in many areas. RHDV2 emerged in France in 2010 and has since spread globally, becoming the dominant circulating strain in most countries including the United States. The two strains are immunologically distinct, meaning that vaccines and immunity developed against RHDV1 do not provide reliable protection against RHDV2, and vice versa. Rabbit owners should work with their veterinarians to understand which viral strains are present in their geographic area and ensure appropriate vaccination coverage. In regions where both strains circulate, bivalent vaccines covering both RHDV1 and RHDV2 may be recommended to provide comprehensive protection against this devastating disease.

RHDV1 is caused by infection with the classic strain of rabbit hemorrhagic disease virus, a non-enveloped, single-stranded RNA virus belonging to the family Caliciviridae and genus Lagovirus. This virus specifically infects lagomorphs, with domestic European rabbits (Oryctolagus cuniculus) being the primary host species. The virus targets hepatocytes (liver cells) with remarkable efficiency, causing acute hepatic necrosis that triggers systemic failure within 24 to 72 hours of infection. RHDV1 represents the original genogroup of rabbit hemorrhagic disease viruses, classified as genotype GI.1 in current nomenclature, distinct from the RHDV2 genotype GI.2 that emerged later. The genetic makeup of RHDV1 contributes to its characteristic age-related susceptibility pattern and host specificity.

No genetic or hereditary factors within rabbits predispose them to RHDV1 infection, as susceptibility is determined at the species level rather than by individual genetics. All domestic European rabbits are equally susceptible to infection once they reach the vulnerable age range. However, the virus itself demonstrates clear age-related pathogenicity, with rabbits under eight to ten weeks of age showing remarkable resistance to fatal disease. This protection in young rabbits is attributed to maternal antibodies passed from vaccinated or previously exposed does to their offspring, as well as potential developmental factors affecting virus receptor expression in young rabbit tissues. Once maternal antibody protection wanes and rabbits mature past this age threshold, they become fully susceptible to fatal RHDV1 infection if not vaccinated.

Environmental factors play crucial roles in RHDV1 transmission and persistence. The virus demonstrates exceptional environmental stability, remaining infectious for months in dried biological material, contaminated surfaces, and decomposing carcasses. It survives freezing and can persist in rabbit meat, fur, and wool products, enabling long-distance spread through commercial trade. Direct transmission occurs through contact between infected and susceptible rabbits, including nasal and oral secretions, feces, urine, and blood. Indirect transmission through fomites is equally important, with the virus spreading via contaminated food, water, bedding, caging, clothing, footwear, and equipment. Mechanical vectors including flies, mosquitoes, and other insects can carry viral particles on their bodies and transfer them to susceptible rabbits. Wild rabbits, rodents, and predatory or scavenging animals may also serve as vectors, carrying the virus between locations.

Risk factors for RHDV1 infection center on exposure opportunities rather than individual rabbit characteristics. Adult rabbits housed outdoors face higher risk due to potential contact with wild lagomorphs, insect vectors, and environmental contamination from infected wildlife. Multi-rabbit facilities including breeding operations, shelters, and rescues face elevated risk because a single introduction can spread rapidly through the population. Attendance at rabbit shows or other gatherings increases exposure through direct contact with unknown rabbits and shared equipment. Purchasing rabbits, hay, or supplies from regions with active RHDV1 circulation introduces potential contaminated materials. Unvaccinated adults in any setting represent the highest-risk category, as they lack both natural and vaccine-induced immunity to protect against infection.

Once RHDV1 enters a susceptible adult rabbit, the disease mechanism unfolds rapidly and devastatingly. The virus likely enters through the oral or nasal route, reaching the liver through the bloodstream where it begins aggressive replication in hepatocytes. Within 24 to 48 hours, massive numbers of liver cells die, releasing cellular contents and inflammatory mediators that trigger systemic inflammatory response and disseminated intravascular coagulation (DIC). In DIC, abnormal clotting occurs throughout small blood vessels, consuming clotting factors and platelets until the blood loses its ability to clot normally. This results in simultaneous microvascular thrombosis causing organ damage and uncontrolled hemorrhaging from multiple sites. The liver damage impairs production of clotting factors and clearance of toxins, accelerating the cascade of organ failure. Death typically occurs within 12 to 72 hours of clinical signs appearing, though in peracute cases rabbits may die without any observable symptoms.

The most common presentation of RHDV1 infection in susceptible adult rabbits is sudden death without preceding clinical signs. This peracute form occurs when the disease progresses so rapidly that the rabbit dies before symptoms become apparent or can be recognized by the owner. Rabbits may appear completely normal in the morning and be found dead later the same day, often with blood visible around the nose or mouth. This sudden presentation is particularly traumatic for owners, who receive no warning that their pet is ill. The peracute form accounts for a significant majority of RHDV1 cases and underscores the critical importance of vaccination, as there is no opportunity for treatment or intervention once infection is established. Rabbit owners should understand that RHDV1 can kill a healthy-appearing rabbit within hours.

In rabbits that survive long enough to develop observable clinical signs, the acute form of RHDV1 typically presents over a 12 to 36 hour course. Early signs may include lethargy, depression, and decreased responsiveness to normal stimuli. The rabbit may sit hunched in one location, showing reluctance to move or interact. Fever may be present initially, though body temperature often drops as the disease progresses into shock. Loss of appetite is typically complete, with affected rabbits refusing both food and water. Given that anorexia lasting more than 12 hours is always an emergency in rabbits due to their need for continuous gut motility, this symptom alone warrants immediate veterinary attention. However, by the time appetite loss is noticed in RHDV1 cases, the disease has usually progressed beyond any possibility of meaningful intervention.

Behavioral changes accompanying RHDV1 infection reflect severe systemic illness and should be interpreted in the context of rabbits' instinct to hide weakness. Affected rabbits may isolate themselves from bonded companions, seeking hiding spots or corners. They typically appear quiet and withdrawn, lacking their normal personality and responsiveness. Some rabbits exhibit teeth grinding (bruxism), which in rabbits indicates significant pain or discomfort. A hunched posture with the abdomen held tight suggests abdominal pain from liver involvement. Because prey animals mask illness until they can no longer maintain the facade, any observable behavioral change in a rabbit may represent advanced disease. Owners familiar with their rabbit's normal behavior patterns are best positioned to recognize subtle changes, though in RHDV1 the course is often too rapid for such recognition to be meaningful.

Physical signs of RHDV1 infection reflect the massive organ damage and hemorrhaging occurring internally. The most characteristic sign is bleeding from body orifices, particularly the nose (epistaxis), which may range from blood-tinged discharge to frank hemorrhage. Blood may also appear at the mouth, around the eyes, or from the rectum. Respiratory signs including labored breathing, rapid respiratory rate, and cyanosis (blue discoloration of mucous membranes indicating poor oxygenation) may be prominent. Because rabbits are obligate nasal breathers, open-mouth breathing indicates severe respiratory compromise and represents a dire emergency. Neurological signs including disorientation, weakness, circling, head pressing, and seizures may occur as the brain is affected by toxins, clotting abnormalities, or direct viral effects.

Symptom progression in acute RHDV1 cases follows a rapid and predictable trajectory toward death. Initial lethargy and anorexia progress within hours to severe depression, respiratory distress, and hemorrhagic signs. Affected rabbits become progressively weaker and less responsive, eventually becoming recumbent and unable to rise. Body temperature drops below normal as circulation fails and shock develops. Hemorrhaging may become more pronounced, with blood pooling around the nose and mouth. Terminal stages may include collapse, coma, seizures, and opisthotonus (severe arching of the head backward due to muscle spasm). Some rabbits emit a terminal cry or vocalization before death. The entire course from first subtle symptoms to death typically spans 12 to 36 hours, though some rabbits die within hours of showing any signs.

Emergency symptoms requiring immediate action include any bleeding from the nose, mouth, or other body opening; sudden collapse or inability to stand; severe respiratory distress or open-mouth breathing; seizures or other neurological abnormalities; complete refusal to eat lasting more than 12 hours; and sudden death of any rabbit companion in the household. If RHDV1 is suspected, the affected rabbit should be immediately isolated from other rabbits to prevent transmission. Contact your veterinarian before transporting the rabbit to allow them to prepare appropriate biosecurity measures. In multi-rabbit households where one adult rabbit dies suddenly, all other adult rabbits should be considered potentially exposed and monitored closely, though they may already be infected given the highly contagious nature of the virus. Vaccination of exposed but apparently healthy rabbits may be recommended as an emergency measure.

Diagnosing RHDV1 infection in living rabbits presents significant challenges because the disease typically kills before diagnostic workup can be completed. When a rabbit presents with clinical signs suggestive of RHDV1, the veterinarian will perform a physical examination noting vital signs, level of consciousness, and any evidence of hemorrhaging. However, findings are often nonspecific and overlap with other conditions. History taking is crucial and should include vaccination status, potential exposure to other rabbits, recent purchases of rabbits or supplies, and any recent deaths among companion rabbits or in local wild rabbit populations. A rabbit-savvy veterinarian familiar with exotic species is essential for appropriate evaluation and management. The veterinarian will also consider the signalment, as RHDV1 characteristically affects adult rabbits over eight weeks of age while sparing younger animals.

Laboratory testing can support suspected RHDV1 diagnosis, though results often come too late to influence outcomes in individual cases. Blood work may reveal abnormalities consistent with liver failure including markedly elevated liver enzymes (ALT, AST), elevated bilirubin, prolonged clotting times, and decreased platelet counts. Anemia may be present from hemorrhage. Chemistry panels may show electrolyte disturbances and evidence of multi-organ dysfunction. However, these findings are not specific to RHDV1 and can occur with other causes of liver failure and coagulopathy. Definitive diagnosis requires detection of the virus itself through PCR (polymerase chain reaction) testing of blood, liver tissue, or other samples. PCR testing can differentiate between RHDV1 and RHDV2 strains, which is important for epidemiological purposes. This testing is typically performed at state veterinary diagnostic laboratories or specialized facilities.

Differential diagnosis for suspected RHDV1 cases includes other conditions causing sudden death, liver failure, or hemorrhaging in adult rabbits. RHDV2 infection causes virtually identical disease but can affect rabbits of any age. Myxomatosis in its peracute form can cause rapid death with hemorrhagic signs. Pasteurellosis (snuffles) can progress to septicemia and death in severe cases. Toxicoses from various sources including plant toxins, rodenticides, and other chemicals may cause hemorrhaging and liver damage. Heat stroke causes rapid collapse and can include hemorrhagic components. Acute GI stasis progressing to hepatic lipidosis can cause death within days, though typically not as rapidly as RHDV1. Trauma causing internal hemorrhage should be considered. The pattern of multiple adult rabbits dying rapidly while young rabbits survive is highly suggestive of RHDV1 specifically.

Definitive diagnosis of RHDV1 is typically made postmortem through necropsy examination and laboratory testing. Necropsy findings characteristic of RHDV1 include an enlarged, pale, or mottled liver showing extensive necrosis; an enlarged, congested spleen; hemorrhages visible in the lungs, heart, kidneys, and other organs; and blood-tinged fluid in body cavities. The trachea often contains bloody froth. Histopathologic examination reveals characteristic patterns of acute hepatic necrosis with inflammation. Tissue samples, particularly from the liver, are submitted for PCR testing to confirm RHDV presence and identify the specific viral genotype. If your adult rabbit dies suddenly and RHDV1 is suspected, preserving the body by refrigeration (not freezing if possible) and requesting necropsy can provide important diagnostic information. This testing helps track disease outbreaks, guides public health response, and provides crucial information for protecting remaining rabbits in the household and community.

No specific treatment or cure exists for RHDV1 infection. The virus causes such rapid and extensive organ damage that meaningful intervention is essentially impossible once clinical disease develops. Antiviral drugs effective against RHDV1 have not been developed, and the precipitous disease course does not allow time for supportive measures to sustain the rabbit until immune responses could clear the infection. This reality makes vaccination the only reliable protection against this devastating disease. For owners facing suspected RHDV1 in their rabbits, the focus necessarily shifts from curative efforts to supportive care that may provide marginal benefit in very mild cases, biosecurity measures to protect other rabbits, and preparation for the likely outcome of death or the need for humane euthanasia.

In the rare instances where a rabbit with suspected RHDV1 presents while still alive and relatively stable, intensive supportive care represents the only treatment option. This may include aggressive intravenous or subcutaneous fluid therapy to support circulation and counter dehydration; warming support to maintain body temperature as shock develops; oxygen supplementation for respiratory compromise; pain management with rabbit-safe analgesics such as meloxicam or buprenorphine; and nutritional support through syringe feeding if the rabbit can swallow safely. However, it must be clearly stated that such measures rarely if ever succeed in changing outcomes, and most rabbits receiving such care will still die from the disease. The decision to attempt intensive treatment must weigh potential benefit against prolongation of suffering.

Surgical intervention plays no role in treating RHDV1 infection. The disease is a systemic viral infection causing multiorgan failure, and no surgical procedure can address this pathology. If a rabbit with suspected RHDV1 required anesthesia for any reason, the risks would be dramatically elevated due to liver failure impairing drug metabolism, coagulopathy increasing bleeding risk, and overall systemic compromise. Rabbit anesthesia already carries higher risks than in dogs and cats, and these risks become prohibitive in a rabbit with active hepatic necrosis. The guidance that rabbits should not be fasted before anesthesia becomes moot in RHDV1 cases, as affected rabbits are already anorexic.

Supportive and palliative care for rabbits suspected to have RHDV1 focuses on comfort rather than cure. The rabbit should be kept in a quiet, warm, stress-free environment away from other rabbits to prevent transmission. Gentle handling and minimal disturbance reduce stress that could accelerate decline. Absorbent bedding should be used and changed as needed if hemorrhaging occurs. Water and favorite foods can be offered, though most affected rabbits refuse both. If the rabbit accepts it, critical care formula may be offered via syringe to provide some nutrition and hydration. Pain medication prescribed by the veterinarian improves comfort during what is typically a terminal illness. Strict isolation from other rabbits in the household is essential, as RHDV1 is highly contagious.

Alternative treatments and complementary therapies have no demonstrated efficacy against RHDV1 and should not be pursued at the expense of conventional supportive care or appropriate euthanasia decisions. No herbal remedies, homeopathic preparations, or nutritional supplements can combat an acute viral infection causing hepatic necrosis. Given the rapid and invariably fatal nature of RHDV1 infection, pursuing alternative treatments wastes precious time and may prolong suffering without any realistic possibility of benefit. The most humane approach for a rabbit with confirmed or strongly suspected RHDV1 showing clinical signs is usually euthanasia to prevent further suffering.

Treatment decisions in suspected RHDV1 cases require honest assessment of prognosis and quality of life considerations. The overwhelming majority of adult rabbits with clinical RHDV1 infection will die from the disease regardless of treatment attempts. Intensive care for a condition with near-zero survival rates is expensive and may prolong suffering without changing outcomes. For most affected rabbits, humane euthanasia is the most compassionate choice, allowing a peaceful death rather than the distressing terminal stages of hemorrhagic disease. For remaining unaffected rabbits in the household, emergency vaccination may be recommended by the veterinarian, though this cannot help rabbits already infected. The focus for survivors should be on strict biosecurity, monitoring for illness, and appropriate vaccination to prevent future cases.

Recovery from RHDV1 infection is exceptionally rare in adult rabbits, as the disease typically causes death in over 90 percent of affected susceptible animals. The few survivors may represent cases of lower viral dose exposure, partial immunity from previous contact with related non-pathogenic caliciviruses, or infection with naturally attenuated viral variants with reduced virulence. Young rabbits under eight to ten weeks of age may become infected but survive without clinical disease due to their age-related resistance, and these animals typically develop immunity that protects them as adults. For the rare adult rabbit that survives acute RHDV1 infection, the recovery period extends over weeks to months as the damaged liver regenerates and other affected organ systems heal. These survivors require careful supportive care and monitoring during the convalescent period.

Post-infection care for RHDV1 survivors centers on supporting liver regeneration and preventing complications. These rabbits need a highly digestible diet emphasizing unlimited grass hay to maintain gut function, limited high-quality pellets, and appropriate fresh leafy greens. Hydration must be carefully monitored, with subcutaneous fluids administered if the rabbit is not drinking adequately on its own. Medications that require hepatic metabolism should be avoided or used with extreme caution until liver function normalizes. Regular veterinary rechecks including blood work to assess liver enzymes and function are essential during recovery. The rabbit should be housed in a clean, quiet, low-stress environment with easy access to food, water, and litter box. Any secondary complications including GI stasis must be addressed promptly.

Factors affecting prognosis in the rare RHDV1 survivors include the severity of initial infection, extent of liver damage sustained, age and baseline health of the rabbit, and quality of supportive care provided during recovery. Rabbits that maintained some appetite and mobility during the acute phase generally have better prognoses than those that became completely debilitated. The presence of concurrent health issues such as dental disease or other infections complicates recovery. Younger adult rabbits may have better regenerative capacity than seniors. Early recognition and institution of supportive care, while unlikely to affect survival in most cases, may benefit the small minority of rabbits capable of surviving the acute infection.

Long-term outlook for RHDV1 survivors is generally favorable once the acute phase is past, though some considerations persist. Survivors develop solid immunity to RHDV1, though this protection does not extend to RHDV2, which is immunologically distinct. Therefore, survivors should still receive RHDV2 vaccination if this strain is present in their geographic area. Some survivors may have residual liver damage that could predispose them to hepatic problems later in life, and periodic monitoring of liver function is advisable. Importantly, recovered rabbits can shed virus in their feces and secretions for several weeks after clinical recovery and should remain isolated from unvaccinated rabbits during this time to prevent transmission. The emotional impact on owners who have experienced RHDV1 in their rabbits can be significant, and survivors serve as reminders of the devastating losses that often accompany this disease.

Vaccination remains the most effective strategy for preventing RHDV1 infection in domestic rabbits. In regions where RHDV1 circulates, specific vaccines targeting this strain are available and should be administered according to veterinary recommendations. In Europe, vaccines such as Filavac and others provide protection against RHDV1, often as combination vaccines that also cover RHDV2 and myxomatosis. The vaccination schedule typically involves initial vaccination at around eight to ten weeks of age, when maternal antibody protection wanes and rabbits become susceptible, followed by annual boosters to maintain immunity. In regions where only RHDV2 is present, such as most of the United States, RHDV1-specific vaccination may not be necessary, though bivalent vaccines covering both strains may be used when available. Consult with a rabbit-savvy veterinarian to determine appropriate vaccination protocols for your geographic area.

Biosecurity measures provide essential additional protection against RHDV1 transmission. Housing rabbits indoors eliminates exposure to wild rabbits, insect vectors, and environmental contamination from wildlife. If outdoor housing is necessary, elevate hutches off the ground and implement comprehensive insect and rodent control programs. Do not allow pet rabbits access to areas where wild rabbits have been present, and do not allow them to graze on outdoor grass or consume foraged plants. Maintain strict hygiene protocols including removing outdoor shoes before entering rabbit areas, washing hands before and after handling rabbits, and disinfecting any equipment shared between rabbits or brought in from outside. Quarantine new rabbits for at least 30 days before introduction to existing pets.

Dietary precautions help minimize risk of introducing RHDV1 through contaminated materials. Purchase hay and feed from reputable suppliers in regions without active outbreaks. Store hay and supplies indoors in sealed containers protected from insects and rodent contamination. Avoid feeding any wild-foraged greens, grasses, or plants that may have contacted wild rabbit droppings or infected materials. Commercially grown vegetables from greenhouses are safer than field-grown produce in endemic areas. While washing vegetables cannot guarantee elimination of viral contamination, thorough rinsing reduces overall contamination risk. If obtaining rabbits from breeders or rescues, inquire about the health history of the source population and require proof of vaccination.

Regular health maintenance and vigilance support overall disease prevention efforts. Establish care with a rabbit-savvy veterinarian who can advise on regional disease risks and appropriate vaccination schedules. Maintain current vaccination records and adhere to booster schedules as recommended. Monitor your rabbit daily for any changes in appetite, behavior, or health status, remembering that rabbits hide illness and subtle changes may be significant. Track food intake, water consumption, and fecal output to establish baselines that help you recognize abnormalities. Avoid taking rabbits to shows, fairs, or other gatherings where exposure to unfamiliar rabbits increases disease risk, particularly during active outbreaks in the region.

Early warning systems and rapid response protocols help limit outbreak spread when RHDV1 is detected. Stay informed about disease outbreaks in your region through state veterinary services and wildlife agencies, which track and report cases. If wild rabbit die-offs are noted in your area, increase biosecurity vigilance immediately. Any sudden unexplained death in an adult rabbit should prompt consideration of RHDV1, particularly if the rabbit was unvaccinated. Report suspected cases to your veterinarian and state animal health authorities. In multi-rabbit households, immediately isolate any rabbit showing signs of illness and consult your veterinarian about emergency measures. Thoroughly disinfect any areas and equipment that may have contacted infected material using appropriate virucidal agents. Proper disposal of deceased rabbits according to veterinary guidance prevents environmental contamination.

Daily management for rabbits in RHDV1-endemic areas requires consistent biosecurity practices integrated into routine care. Establish habits of removing outdoor footwear before entering rabbit spaces and washing hands before and after handling your rabbits. Feed only commercial hay, pellets, and store-bought vegetables rather than foraged items that may be contaminated. Monitor your rabbit daily for any changes in appetite, energy level, or behavior, keeping in mind that subtle changes in prey animals may indicate significant illness. Check litter box output regularly, as changes in fecal pellet production can be early indicators of health problems. If you have multiple rabbits, observe their social interactions for any signs of one individual isolating from the group or being rejected by companions, which may indicate that the rabbit is unwell.

Environmental management supports both disease prevention and overall rabbit health. Indoor housing is strongly preferred as it eliminates most exposure routes for RHDV1. Maintain the rabbit's living space in a quiet area away from temperature extremes and drafts, with good ventilation but without direct airflow on the rabbit. Keep temperatures comfortable between 60 and 70 degrees Fahrenheit, as heat stress can compromise immune function. Implement comprehensive insect control including screens on windows and doors, elimination of standing water where mosquitoes breed, and use of rabbit-safe fly control methods. Ensure effective rodent control using methods that pose no poisoning risk to your rabbit. Clean and disinfect housing and accessories regularly using rabbit-safe products.

Maintaining quality of life while implementing disease prevention measures requires thoughtful balance. While biosecurity limits some activities, rabbits still need adequate exercise space, mental stimulation, and social interaction for wellbeing. Provide a large indoor exercise area or rabbit-proofed room where your rabbit can hop freely and engage in natural behaviors. Offer enrichment through toys, tunnels, hiding spaces, and novel items to explore. Maintain bonded pairs together, as the social companionship is important for rabbit welfare. Spend quality time with your rabbit through gentle interaction, grooming, and simply sharing quiet space. Ensure continuous access to unlimited grass hay, which supports both dental and digestive health while providing behavioral enrichment.

Ongoing monitoring and veterinary partnership remain essential components of preventive management. Schedule regular wellness examinations with a rabbit-savvy veterinarian every six to twelve months for healthy adults, with more frequent visits for seniors or rabbits with health issues. Keep vaccinations current according to your veterinarian's recommendations for your geographic area. Monitor body weight weekly using a small scale, as weight changes often indicate developing health problems. Track daily food consumption and note any decreases in appetite, which in rabbits always warrants attention. If any rabbit in your household dies unexpectedly, consult your veterinarian about the advisability of postmortem examination to determine cause of death.

Owner education and support resources strengthen your ability to protect your rabbits from RHDV1. The House Rabbit Society, local rabbit rescue organizations, and rabbit veterinary specialists provide valuable information about disease prevention and general care. Online communities connect rabbit owners to share experiences and alerts about local disease activity. Maintain relationship with your veterinarian's office for updates on regional disease status and vaccine availability. Consider the full financial commitment of rabbit ownership including vaccination costs, appropriate housing and supplies, and emergency veterinary care. Having resources and contingency plans in place for both routine care and emergencies ensures you can provide optimal protection for your rabbits. While RHDV1 is a devastating disease, consistent vaccination and biosecurity practices dramatically reduce risk, allowing you to focus on enjoying your relationship with your rabbits.

RHDV1 affects all domestic rabbit breeds equally, as susceptibility is determined by species and age rather than breed characteristics. All domestic European rabbits (Oryctolagus cuniculus) over eight to ten weeks of age are fully susceptible to fatal RHDV1 infection if unvaccinated. This includes all common pet breeds from small varieties like Netherland Dwarfs, Holland Lops, and Mini Rex to medium breeds such as Dutch, Lionhead, and English Spot, to large breeds including Flemish Giant, French Lop, and Checkered Giant. Mixed breed rabbits are equally susceptible. The key factor determining susceptibility is not breed but age—rabbits under eight weeks typically resist fatal disease due to maternal antibodies and developmental factors, while older rabbits face high mortality rates. This age threshold is specific to RHDV1 and differs from RHDV2, which can kill rabbits of any age.

Certain populations face elevated risk based on management and exposure factors rather than breed. Unvaccinated adult rabbits represent the highest-risk category. Rabbits in multi-rabbit facilities including breeding operations, shelters, and rescue organizations face increased risk because RHDV1 spreads rapidly through populations once introduced. Show rabbits attending events with multiple rabbit populations have greater exposure opportunities. Outdoor-housed rabbits have more potential contact with wild rabbits, insects, and environmental contamination. Rabbits in geographic regions with endemic RHDV1 circulation or recent outbreaks face ongoing exposure risk. Commercial meat and fur rabbits in affected regions have historically experienced devastating losses when RHDV1 was introduced into facilities. Laboratory rabbits may be at risk if biosecurity is compromised.

Vaccination recommendations apply uniformly to all breeds and types once rabbits reach susceptible age. In regions where RHDV1 circulates, all rabbits over eight to ten weeks of age should be vaccinated unless veterinary guidance indicates otherwise. Breeders should vaccinate all breeding adults and begin vaccinating offspring at appropriate age according to veterinary protocols. Rescue organizations should implement vaccination programs for all adult rabbits in their care. Show rabbits should be fully vaccinated well before any events where they may contact other rabbits. Pet owners should confirm vaccination status of newly acquired rabbits and complete vaccination series as needed under veterinary guidance. In areas where RHDV2 has replaced RHDV1 as the dominant strain, RHDV1 vaccination may be less critical, but bivalent vaccines covering both strains provide the most comprehensive protection where available.

Several conditions may complicate RHDV1 infection or develop as sequelae in the rare survivors. Secondary bacterial infections may occur as the immune system becomes compromised during acute viral infection. Hepatic lipidosis (fatty liver disease) may develop if surviving rabbits experience anorexia during recovery, as rabbits are prone to this condition when they stop eating. GI stasis, the life-threatening slowdown of intestinal motility, commonly develops secondary to any serious illness in rabbits and may complicate both acute disease and recovery phases. Any condition that causes anorexia or pain can trigger GI stasis in rabbits, making supportive feeding and pain management critical. Recovered rabbits that shed virus for extended periods pose transmission risk to unvaccinated companions, creating household management challenges.

Conditions with similar presentation must be considered in differential diagnosis of suspected RHDV1 cases. RHDV2 infection causes essentially identical disease but affects rabbits of all ages rather than primarily adults. Myxomatosis presents with different primary signs in classic form but can cause rapid death in peracute presentations. Bacterial septicemia from various causes including severe pasteurellosis may cause rapid decline and death. Heat stroke causes sudden collapse and can include hemorrhagic components in severe cases. Toxicoses from poisonous plants, rodenticides, or other chemicals can cause liver damage, hemorrhaging, and death. Acute GI stasis complicated by hepatic lipidosis can cause death, though typically over several days rather than hours. Trauma causing internal hemorrhage may present as sudden death.

Complications arising from RHDV1 outbreaks extend beyond immediate health effects. Environmental contamination persists for months after infected rabbits die or recover, as the virus remains stable on surfaces and in organic material. This contamination poses ongoing risk to unvaccinated rabbits introduced to the area. Fomite transmission through contaminated equipment, clothing, and supplies can spread disease to new locations. The economic and emotional impact of losing rabbits to RHDV1 can be devastating, particularly for breeders or owners of bonded groups. Secondary effects on household rabbit populations may include disruption of social bonds when companions die and stress on surviving rabbits from environmental changes during outbreak response. Wildlife conservation concerns arise when RHDV1 spreads from domestic to wild rabbit populations.